TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2025

Pembrolizumab Plus Docetaxel Versus Docetaxel for Previously Treated Metastatic Castration-Resistant Prostate Cancer: The Randomized, Double-Blind, Phase III KEYNOTE-921 Trial.

Daniel P Petrylak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.